Bozor qiymati: immunome.com (IMNM)
GURU.Markets platformasidagi Immunome, Inc. (IMNM) kompaniyasining ushbu kunlik narxlar grafigi, bozor kapitalizatsiyasi 2.13 miqdorini tashkil etgan joyda, biomateriallarning aniq yetkazib berilishi va saratonni davolash uchun maqsadli ADC dori vositalarini ishlab chiqish o'rtasidagi samarali sinergiyani tasdiqlaydi. Biznes radioligandlar sohasidagi ilg'or ilmiy tadqiqotlarga, shuningdek, o'simta terapiyasining yangi usullarini yaratish uchun global biotexnologiya yetakchilari bilan yaqin hamkorlikka tayanadi.
Immunome Bio (IMNM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- bozor narxi va tahlilchilarning maqsadli narxlari:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- kompaniyaning jami qarzi va likvidligi ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Immunome, Inc.|IMNM - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati Immunome, Inc.|IMNM - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati Immunome Bio|IMNM - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli qarzi Immunome|Tezkor likvidlik koeffitsiyenti immunome.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMNM - Sof foyda|Kelajakdagi foyda Immunome, Inc.|IMNM - Kompaniya qiymatining sof foydaga nisbati|Forvard P/E multiplikatori Immunome Corp|IMNM - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Immunome Bio|IMNM - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Immunome|IMNM - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi immunome.com|IMNM - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Immunome, Inc.
Kompaniyaning fundamental tahlili:IMNM (Immunome)
Immunome, Inc. (IMNM) kompaniyasining istiqbollari bozor sikllaridan ko'ra ko'proq antitelalarni ishlab chiqish samaradorligiga bog'liq bo'lib, bu kapital tannarxini tadqiqot va ishlanmalar (R&D) muvaffaqiyatiga sezgir qiladi. Hozirda 2.13 miqdorida bo'lgan emitentning bozor kapitalizatsiyasini tahlil qilib, investor joriy aksiya narxi va aksiyalar hajmining ko'paytmasini ko'radi, bu esa aktivlarning haddan tashqari qimmat baholanganini yoki fundamental yetishmovchilikni tezda aniqlash imkonini beradi.
Muhim raqobatchilar
Bozor qiymati argenx ARGX|BNTX - Bozor bahosi|ABVX - Bozor qiymati|ADMA (ADMA Corp) - Bozor kapitallashuvi|Protagonist Therapeutics (PTGX) - Bozor qiymati|Bozor bahosi immunovant.com|Bozor qiymati Kiniksa|Grifols SA - Bozor bahosi|Bozor kapitallashuvi ADPT|CLDX (Celldex Corp) - Bozor qiymati|Bozor kapitallashuvi AUPH (Aurinia Pharmaceuticals)|Bozor kapitallashuvi biocryst.com BCRX|VERA - Bozor qiymati|Bozor qiymati DNTH (Dianthus Therapeutics Inc)|Pharvaris Corp (PHVS) - Bozor qiymati|Bozor bahosi AbCellera Biologics Inc.|TRML (Tourmaline Bio, Inc.) - Bozor kapitallashuvi|Bozor kapitallashuvi precigen.com|Bozor bahosi PHAR (Pharming Group)|NKTR (Nektar Therapeutics Inc) - Bozor qiymati|Bozor kapitallashuvi UPB (Upstream Bio Corp)|Bozor kapitallashuvi Zenas Corp (ZBIO)|GOSS - Bozor qiymati|kalvista.com (KALV) - Bozor bahosi|Septerna (SEPN) - Bozor qiymati|Bozor bahosi Pieris Pharma|Bozor bahosi SVRA|Bozor kapitallashuvi Rigel Corp|Bozor qiymati AnaptysBio, Inc. (ANAB)|astriatx.com - Bozor kapitallashuvi|Bozor kapitallashuvi ENGN (enGene)|rapt.com (RAPT) - Bozor qiymati|Aerovate - Bozor kapitallashuvi|Bozor kapitallashuvi Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics (KYTX) - Bozor qiymati|Bozor bahosi tizianalifesciences.com|Bozor qiymati Cabaletta Bio|Bozor bahosi Ventyx Biosciences Inc. (VTYX)|Bozor bahosi THTX (Theratechnologies Inc)|Bozor kapitallashuvi Avalo Therapeutics Inc (AVTX)|Bozor qiymati Eledon Pharmaceuticals ELDN|AGEN: Bozor kapitallashuvi|CLYM - Bozor qiymati|Bozor qiymati zurabio.com|aTyr (ATYR) - Bozor qiymati|Bozor bahosi Adagene Inc.|IMA (ImageneBio) - Bozor kapitallashuvi|Bozor qiymati Shattuck Therapeutics STTK|Bozor bahosi EQ (Equillium, Inc.)|CNTB (connectbiopharm.com) - Bozor qiymati|Bozor kapitallashuvi IMUX (Immunic)|Bozor kapitallashuvi Atara Biotherapeutics, Inc. (ATRA)|IFRX - Bozor qiymati|XFOR (x4pharma.com) - Bozor kapitallashuvi|ACET: Bozor kapitallashuvi|Bozor bahosi Celularity|Bozor bahosi INMB|Barinthus Biotherapeutics Corp (BRNS) - Bozor kapitallashuvi|Bozor kapitallashuvi KZR|Bozor kapitallashuvi sabbiotherapeutics.com|Bozor qiymati Akari Therapeutics Plc AKTX|ENLV - Bozor bahosi|QTTB - Bozor qiymati|GOVX (GeoVax Corp) - Bozor kapitallashuvi|Edesa Biotech, Inc. (EDSA) - Bozor qiymati|Bozor bahosi ibioinc.com|Bozor qiymati Carisma Therapeutics Inc|XTL Biopharmaceuticals Ltd - Bozor bahosi|Bozor kapitallashuvi BOLT|HCWB (hcwbiologics.com) - Bozor qiymati|Bozor kapitallashuvi APVO (Aptevo Therapeutics Inc.)|Bozor kapitallashuvi aimimmuno.com AIM|ADTX - Bozor qiymati|Bozor qiymati GRI (GRI Bio Inc)|XORTX (XRTX) - Bozor qiymati|Bozor bahosi Vyome Therapeutics|REVB (Revelation Biosciences) - Bozor kapitallashuvi|Bozor kapitallashuvi indaptusrx.com|Bozor bahosi SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Bozor qiymati|Bozor kapitallashuvi AFMD (Affimed N.V.)|Bozor kapitallashuvi Allakos Inc (ALLK)|HOOK - Bozor qiymati|IGM Biosciences, Inc. (IGMS) - Bozor bahosi|iTeos Therapeutics, Inc. (ITOS) - Bozor qiymati|Bozor bahosi Ocean Biomedical Inc|Bozor bahosi TCBP|Bozor kapitallashuvi Third Harmonic Bio Inc
